Drugs that contain Drospirenone; Ethinyl Estradiol; Levomefolate Calcium
1. Drug name - BEYAZ
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6441168 | BAYER HLTHCARE | Stable crystalline salts of 5-methyltetrahydrofolic acid |
Jul, 2022
(a month ago) | |
| CN1277197A | BAYER HLTHCARE | Stable Crystalline Salt Of 5-Methyl Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| CN1154648C | BAYER HLTHCARE | 5-Stable Crystalline Calcium Salt Of Methyl Tetrahydrofolate And Preparation Method And Use Thereof |
Apr, 2020
(2 years ago) | |
| EP1044975B1 | BAYER HLTHCARE | Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP1044975A1 | BAYER HLTHCARE | Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2192120B1 | BAYER HLTHCARE | Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2192120A1 | BAYER HLTHCARE | Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2194057B1 | BAYER HLTHCARE | Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2189459B1 | BAYER HLTHCARE | Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2194057A1 | BAYER HLTHCARE | Stable Crystalline Calcium Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| EP2189459A1 | BAYER HLTHCARE | Stable Crystalline Salt Of 5-Methyl-(6S)-Tetrahydrofolic Acid |
Apr, 2020
(2 years ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8617597 | BAYER HLTHCARE | Pharmaceutical composition containing a tetrahydrofolic acid |
Feb, 2030
(7 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 3MG,N/A;0.02MG,N/A;0.451MG,0.451MG | TABLET;ORAL | Prescription |
2. Drug name - SAFYRAL
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8617597 | BAYER HLTHCARE | Pharmaceutical composition containing a tetrahydrofolic acid |
Feb, 2030
(7 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 3MG,N/A;0.03MG,N/A;0.451MG,0.451MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.